The FDA’s review of the data on open power morcellation was “inadequate, irresponsible” and a “disservice to women”

Article Type

Audio

Changed

Mon, 10/01/2018 - 08:45

Display Headline

The FDA’s review of the data on open power morcellation was “inadequate, irresponsible” and a “disservice to women”

Author(s)

William H. Parker, MD

Author and Disclosure Information

William H. Parker, MD

Dr. Parker is Director of Minimally Invasive Gynecologic Surgery at University of California at Los Angeles Medical Center in Santa Monica, California, and a past President of AAGL.

The speaker reports no financial relationships relevant to this audiocast.

Issue

OBG Management - 26(11)

Publications

MDedge ObGyn

OBG Management

Topics

Surgery

Legacy Keywords

FDA,uterine malignancy,benign hysterectomy,laparoscopic morcellation,vaginal morcellation,morcellation through a mini laparotomy,

Sections

Expert Commentary

Author(s)

William H. Parker, MD

Author(s)

William H. Parker, MD

Author and Disclosure Information

William H. Parker, MD

Dr. Parker is Director of Minimally Invasive Gynecologic Surgery at University of California at Los Angeles Medical Center in Santa Monica, California, and a past President of AAGL.

The speaker reports no financial relationships relevant to this audiocast.

Author and Disclosure Information

William H. Parker, MD

Dr. Parker is Director of Minimally Invasive Gynecologic Surgery at University of California at Los Angeles Medical Center in Santa Monica, California, and a past President of AAGL.

The speaker reports no financial relationships relevant to this audiocast.